Is Melatonin OK for Kids? Safety, Dosing and Risks

Melatonin is generally considered safe for short-term use in children, but it comes with important caveats. The American Academy of Pediatrics (AAP) positions it as a temporary tool, not a long-term fix, and recommends that parents work with a pediatrician before starting it. Melatonin is not a sleeping pill. It’s a hormone that helps signal to the body that it’s time to sleep, and in children, it works best alongside consistent bedtime habits rather than as a replacement for them.

What the AAP Recommends

The AAP encourages parents and pediatricians to approach melatonin “cautiously and carefully.” Their guidance treats it as a short-term bridge: something to help kids get rest while you’re still building good sleep routines. It can also help older children and teens reset their internal clocks after vacations, summer breaks, or other schedule disruptions.

For children with neurodevelopmental conditions like autism or ADHD, melatonin plays a more established role. The AAP acknowledges its use in these populations but stresses that a pediatrician should monitor it closely. The key message across the board: melatonin should not be the first thing you try, and it should not be the only thing you try.

Dosing: Less Than You Think

Most melatonin products marketed for adults contain 3 to 10 mg per dose, but children typically need far less. Many kids respond well to just 0.5 mg or 1 mg, taken 30 to 90 minutes before bedtime. Even children with ADHD rarely need more than 3 to 6 mg. Starting at the lowest possible dose and working up only if needed is the standard approach.

Timing matters as much as dose. Giving melatonin too early or too late in the evening can shift your child’s sleep window in the wrong direction. A general guideline is 30 to 90 minutes before the target bedtime, but the ideal timing can vary by child.

Common Side Effects

Short-term side effects reported in children include morning drowsiness, headache, dizziness, diarrhea, and occasional bedwetting. These tend to be mild. Clinical trials in children with autism and related conditions have not identified serious safety concerns with supervised use, even in studies lasting up to a year.

The Puberty Question

One concern that surfaces frequently is whether supplemental melatonin could interfere with puberty. The body’s natural melatonin levels gradually decline before puberty begins, so there’s a theoretical worry that adding extra melatonin could delay that process. A systematic review published in The Lancet’s eClinicalMedicine looked at this directly. Three studies found little or no influence on pubertal development after 2 to 4 years of continuous use. One study that tracked children over more than 7 years flagged a potential delay, but the researchers noted significant methodological limitations. The current evidence is reassuring for shorter-term use but incomplete for very long durations.

A Major Problem: What’s Actually in the Bottle

Here’s something many parents don’t realize: melatonin is sold as a dietary supplement in the United States, not as a regulated medication. The FDA does not approve it, test it for purity, or verify that what’s on the label matches what’s inside. An analysis of 25 melatonin gummy products found that the actual melatonin content ranged from 74% to 347% of the amount listed on the label. That means a product claiming to contain 1 mg could actually contain nearly 3.5 mg.

This is especially concerning for children, where precise dosing matters. If you’re giving your child melatonin, choosing a product from a brand that uses third-party testing (look for a USP or NSF seal on the label) reduces the risk of getting an inaccurate dose.

Accidental Ingestion Is a Real Risk

Melatonin gummies often look and taste like candy, and accidental ingestions by young children have skyrocketed. CDC data shows that pediatric melatonin ingestions reported to poison control increased 530% between 2012 and 2021, rising from about 8,300 cases to over 52,500 in a single year. The sharpest jump, nearly 38%, happened between 2019 and 2020, coinciding with the pandemic.

Most cases were mild. Among children who received medical care, about 72% were discharged without hospitalization. But 14.7% were hospitalized, 1% required intensive care, and five children needed mechanical ventilation. Two children under age 2 died. By 2021, melatonin accounted for nearly 5% of all pediatric poisoning reports, up from 0.6% in 2012. If you keep melatonin in your home, store it out of reach and in a child-resistant container, just as you would with any medication.

Stronger Evidence for Autism and ADHD

The most robust research on pediatric melatonin comes from studies of children with autism spectrum disorder. Sleep problems are extremely common in this population, and melatonin has consistently shown meaningful benefits. A meta-analysis of five controlled trials found that children with autism who took melatonin fell asleep about 66 minutes faster and slept an average of 73 minutes longer per night. A larger trial of 125 children with autism, ADHD, or neurogenetic disorders found that a slow-release formulation added nearly an hour of total sleep compared to placebo, without causing earlier wake-ups.

A follow-up study tracked 95 of those children for up to a year and found the slow-release melatonin remained safe over that period. For families managing neurodevelopmental conditions, melatonin is one of the better-supported interventions for sleep, though it still works best as part of a broader approach.

Try Sleep Habits First

Before reaching for melatonin, the AAP and sleep researchers recommend establishing consistent sleep routines. The techniques with the strongest evidence include:

  • Bedtime fading: Temporarily setting bedtime later to match when your child actually falls asleep, then gradually moving it earlier as sleep onset improves.
  • Positive bedtime routines: A predictable sequence of calming activities (bath, book, lights out) that signals to the body it’s time to wind down.
  • Environmental changes: Keeping the bedroom cool, dark, and quiet. Removing screens at least 30 to 60 minutes before bed. Blue light from tablets and phones suppresses the body’s own melatonin production.

Research on children with autism, who face some of the most persistent sleep challenges, found that combining behavioral strategies with environmental modifications was more effective than any single approach alone. For neurotypical children with garden-variety bedtime resistance, these changes alone often resolve the problem without supplements.